Pfizer Begins Vaccine Trials on 3 to 11-Year-Olds in the US

The American pharmaceutical giant Pfizer announced it is now expanding its coronavirus vaccine clinical trials for children ages 5 to 11. Read the full story on GreekReporter.com.

READ THE ORIGINAL POST AT greekreporter.com